Global Allogenic Cell Therapies Market worth $ 2 42 Billion by 2030 - Exclusive Report by InsightAce Analytic einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Novel T-Cell Immunotherapies Market– Industry.
Takeda Pharmaceutical Co Ltd has exercised its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy. Through the acquisition, Takeda will obtain GammaDelta’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy platforms, which includes both…